• 1. An atomically efficient, highly stable and redox active Ce0.5Tb0.5Ox (3% mol.)/MgO catalyst for total oxidation of methane?
  Juan J. Sánchez,Miguel López-Haro,Juan C. Hernández-Garrido,Ginesa Blanco,Miguel A. Cauqui,José M. Rodríguez-Izquierdo,José A. Pérez-Omil,José J. Calvino,María P. Yeste J. Mater. Chem. A, 2019,7, 8993-9003
• 2. An air-stable organometallic polymer containing titanafluorene moieties obtained by the Sonogashira–Hagihara cross-coupling polycondensation?
  Alvin Tanudjaja,Shinsuke Inagi,Fusao Kitamura,Toshikazu Takata,Ikuyoshi Tomita Dalton Trans., 2021,50, 3037-3043
• 3. Alternative mixtures to R-600a. Theoretical assessment and experimental energy evaluation of binary mixtures in a commercial cooler: Mélanges alternatifs au R-600a. évaluation théorique et évaluation énergétique expérimentale de mélanges binaires dans un refroidisseur commercial.
  DanielCalleja-Anta,DanielSánchez,LauraNebot-Andres,RamónCabello,RodrigoLlopis
• 4. Acenaphthenic hopanoids, a novel series of aromatised
  Teresita Carrillo-Hernández,Philippe Schaeffer,Pierre Albrecht Chem. Commun., 2001, 1976-1977
• 5. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219

• Solvents and Organic Chemicals Organic Compounds Phenylpropanoids and polyketides Coumarins and derivatives Psoralens

Comprehensive Analysis of 7H-Furo[3,2-g][1]benzopyran-7-one, 4-(2,3-dihydroxy-3-methylbutoxy)- (CAS No. 24724-52-5)

The compound 7H-Furo[3,2-g][1]benzopyran-7-one, 4-(2,3-dihydroxy-3-methylbutoxy)- (CAS No. 24724-52-5) is a specialized organic molecule that has garnered significant attention in the fields of pharmaceutical research and natural product chemistry. This compound belongs to the furocoumarin family, a class of molecules known for their unique photochemical properties and potential therapeutic applications. Researchers are particularly interested in its structural features, which include a furan ring fused to a benzopyranone core, along with a dihydroxy-3-methylbutoxy side chain. These characteristics make it a promising candidate for further study in drug development and bioactive compound synthesis.

In recent years, the demand for natural-derived compounds with medicinal properties has surged, driven by the growing interest in alternative therapies and sustainable healthcare solutions. 7H-Furo[3,2-g][1]benzopyran-7-one, 4-(2,3-dihydroxy-3-methylbutoxy)- has been identified as a potential key player in this space due to its structural similarity to other bioactive coumarin derivatives. Scientists are exploring its possible roles in anti-inflammatory, antioxidant, and enzyme inhibition applications, which align with current trends in precision medicine and personalized healthcare.

The synthesis and characterization of CAS No. 24724-52-5 involve advanced techniques such as nuclear magnetic resonance (NMR) spectroscopy and high-performance liquid chromatography (HPLC). These methods ensure the purity and consistency of the compound, which is critical for its use in research and development. Additionally, the compound's solubility and stability under various conditions are being studied to optimize its formulation for potential commercial applications. This aligns with the broader industry focus on green chemistry and eco-friendly synthesis methods.

One of the most frequently asked questions about 7H-Furo[3,2-g][1]benzopyran-7-one, 4-(2,3-dihydroxy-3-methylbutoxy)- is its potential role in skin care and cosmeceuticals. Given the rising popularity of plant-based ingredients in the beauty industry, this compound's photochemical properties could make it a valuable addition to formulations targeting UV protection or anti-aging. However, further clinical studies are needed to validate these applications.

From a commercial perspective, the global market for specialty chemicals and fine chemicals is expanding, with increasing investments in research and development (R&D). CAS No. 24724-52-5 represents a niche but growing segment, particularly in the pharmaceutical intermediates and nutraceutical ingredients sectors. Companies specializing in custom synthesis and contract manufacturing are actively exploring its production scalability to meet potential demand.

In conclusion, 7H-Furo[3,2-g][1]benzopyran-7-one, 4-(2,3-dihydroxy-3-methylbutoxy)- (CAS No. 24724-52-5) is a compound of significant scientific and commercial interest. Its unique structure, combined with the growing demand for bioactive natural products, positions it as a promising candidate for future innovations in healthcare, cosmetics, and material science. As research progresses, this compound may unlock new possibilities in drug discovery and sustainable chemistry.

• 26091-73-6((-)-Oxypeucedanin)
• 19573-01-4((Rac)-Byakangelicin)
• 2643-85-8(Oxypeucedanin hydrate)
• 482-25-7(Byakangelicin)
• 133164-11-1((-)-Oxypeucedanin hydrate)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)